Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
Gabriele Stengel, Eva Kristina Bee Hautarztpraxis Stengel and Bee, Münster, Germany Abstract: Botulinum toxin type A (BTX-A) preparations are widely used nonsurgical treatments for facial wrinkles. Higher doses of BTX-A are also used for therapeutic purposes in the treatment of conditions...
Guardado en:
Autores principales: | Stengel G, Bee EK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50e84409bf0040daaa9cca4fcbab2894 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study
por: Prager W, et al.
Publicado: (2013) -
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
por: Koenraad De Boulle, et al.
Publicado: (2010) -
Cosmetic use of botulinum toxin type A in the elderly
por: Christine M Cheng
Publicado: (2007) -
Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
por: Michael P Cannito, et al.
Publicado: (2008) -
Spirituality and well being among elders: differences between elders with heart failure and those without heart failure
por: Mary T Quinn Griffin, et al.
Publicado: (2008)